UBS ASSET MANAGEMENT AMERICAS INC – Regeneron Pharmaceuticals, Inc. Transaction History
UBS ASSET MANAGEMENT AMERICAS INC portfolio value:
$414.00M
portfolio value
UBS ASSET MANAGEMENT AMERICAS INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.42% | -2.55K shares | 57.23M | $688.87 | 600.99K |
| Q2 2022 | share | Increase | +4.75% | 27.38K shares | -45.62M | $591.13 | 603.54K |
| Q1 2022 | share | Decrease | -5.22% | -31.75K shares | 18.49M | $698.42 | 576.16K |
| Q4 2021 | share | Increase | +15.97% | 83.70K shares | 66.67M | $642.51 | 607.91K |
| Q3 2021 | share | Decrease | -8.55% | -49.00K shares | -2.92M | $605.18 | 524.21K |
| Q2 2021 | share | Decrease | -7.30% | -45.12K shares | 27.60M | $558.54 | 573.21K |
| Q1 2021 | share | Decrease | -3.90% | -25.09K shares | -18.28M | $473.14 | 618.34K |
| Q4 2020 | share | Increase | +8.65% | 51.24K shares | -20.64M | $483.11 | 643.44K |
| Q3 2020 | share | Increase | +17.95% | 90.14K shares | 18.39M | $559.78 | 592.19K |
| Q2 2020 | share | Increase | +50.28% | 167.96K shares | 149.97M | $623.65 | 502.05K |
| Q1 2020 | share | Increase | +0.86% | 2.84K shares | 38.75M | $488.29 | 334.09K |
| Q4 2019 | share | Decrease | -0.80% | -2.66K shares | 31.74M | $375.48 | 331.25K |
| Q3 2019 | share | Decrease | -18.32% | -74.87K shares | -35.32M | $277.4 | 333.91K |
| Q2 2019 | share | Decrease | -0.22% | -892 shares | -40.27M | $313 | 408.79K |
| Q1 2019 | share | Increase | +26.31% | 85.32K shares | 47.07M | $410.62 | 409.68K |
| Q4 2018 | share | Increase | +1.91% | 6.07K shares | -7.45M | $373.5 | 324.35K |
| Q3 2018 | share | Decrease | -6.51% | -22.17K shares | 11.14M | $404.04 | 318.28K |
| Q2 2018 | share | Decrease | -0.19% | -634 shares | -3.83K | $344.99 | 340.45K |
| Q1 2018 | share | Decrease | -38.38% | -212.40K shares | -90.63M | $344.36 | 341.09K |
| Q4 2017 | share | Increase | +93.49% | 267.44K shares | 80.19M | $375.96 | 553.50K |
| Q3 2017 | share | Decrease | -2.48% | -7.26K shares | -16.16M | $447.12 | 286.05K |
| Q2 2017 | share | Increase | +1.93% | 5.56K shares | 32.55M | $491.14 | 293.32K |
| Q1 2017 | share | Decrease | -12.21% | -40.03K shares | -8.81M | $387.51 | 287.76K |
| Q4 2016 | share | Decrease | -2.19% | -7.32K shares | -14.39M | $367.09 | 327.80K |
| Q3 2016 | share | Decrease | -31.56% | -154.56K shares | -36.28M | $402.02 | 335.12K |
| Q2 2016 | share | Increase | +3.37% | 15.98K shares | 274K | $349.23 | 489.69K |
| Q1 2016 | share | Increase | +10.09% | 43.41K shares | -62.85M | $360.44 | 473.71K |